Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration

Hypertension

Volumn 28, Issue 2, 1996, Pages 159-168

  Yasunari, Kenichi ^a   Kohno, Masakazu ^a   Kano, Hiroaki ^a   Yokokawa, Koji ^a   Horio, Takeshi ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

glucose; muscle, vascular, smooth; natriuretic peptides; protein kinases

Indexed keywords

PHOSPHOLIPASE D; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029784955     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.2.159     Document Type: Article

References (44)

1. The DCCT Research group. Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? N Engl J Med. 1988;318:246-250.
2. Stearns S, Schlesinger MJ, Rudy A. Incidence and clinical significance of coronary artery disease in diabetes mellitus. Arch Intern Med. 1947;80:463-474.
3. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
4. Kondo K, Inui H, Konishi F, Inagami T. Phospholipase D mimics platelet-derived growth factor as a competence factor in vascular smooth muscle cells. J Biol Chem. 1992;267:23609-23616.
5. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications of cellular regulation. Nature. 1988;334:661-665.
6. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem. 1991;266:1265-1268.
7. Kariya I, Kawahara Y, Tsuda T. Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 1987;63:251-255.
8. Chinkers M, Garbers DL. Signal transduction by guanylyl cyclases. Annu Rev Biochem. 1991;60:553-575.
9. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res. 1992;71:34-39.
10. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990; 86:1690-1697.
11. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Horio T, Takeda T. Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle. Hypertension. 1992;19:314-319.
12. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A. 1989;86:5141-5145.
13. Lee TS, MacGregor LC, Fluharty SJ, King GL. Differential regulation of protein kinase C and (Na, K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. J Clin Invest. 1989;83:90-94.
14. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Takeda T. Glucocorticoid and atrial natriuretic peptide receptors on vascular smooth muscle. Hypertension. 1990;16:581-586.
15. Yasunari K, Kohno M, Yokokawa K, Horio T, Takeda T. Dopamine DA1 receptors on vascular smooth muscle cells are regulated by glucocorticoid and sodium chloride. Am J Physiol. 1994;267: R628-R634.
16. Yasunari K, Kohno M, Balmforth AJ, Murakawa K, Yokokawa K, Kurihara N, Takeda T. Glucocorticoid and dopamine-I receptors on vascular smooth muscle. Hypertension. 1989;13:575-581.
17. 1 receptors on vascular smooth muscle. Am J Physiol. 1993;264:F24-F30.
18. Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest. 1991;87:1999-2004.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
20. Vindelov LL, Christiansen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis cytometry. Cytometry. 1983;3:323-327.
21. Kiss J, Crilly KS. Adenosine triphosphate (ATP) and other nucleotides stimulate the hydrolysis of phosphatidyl ethanolamine in intact fibroblasts. Lipids. 1991;26:777-780.
22. Wallenstein SW, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
23. Natarajan R, Gonzales N, Xn L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun. 1992;187:552-560.
24. House C, Kemp BE. Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science. 1987;238:1726-1728.
25. Amazu M, Parker RE, Harvie BR, Ichikawa I, Ken V. Downregulation of endothelin-I receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol. 1991;17(suppl 7):S500-S512.
26. Williams B, Schrier RW. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes. 1992;41:1464-1472.
27. Nishizuka Y. Protein kinase C and lipid signaling of sustained cellular responses. FASEB J. 1995;9:484-496.
28. Exon JH. Signaling through phosphatidylcholine breakdown. J Biol Chem. 1990;265:1-5.
29. Eldar H, Ben-Av P, Schmidt US, Livneh E, Liscovitch M. Up-regulation of phospholipase D activity induced by overexpression of protein kinase C-α. J Biol Chem. 1993;268:12560-12564.
30. Balboa MA, Firestein BL, Godson C, Bell KS, Insel PA. Protein kinase Ca mediates phospholipase D activation by nucleoudes and phorbol ester in madin-darby canine kidney cells. J Biol Chem. 1994;269:10511-10516.
31. Kunisaki M, Bursell SE, Umeda F, Nawata H, King GL. Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes. 1994;43:1372-1377.
32. Williams B, Tsai P, Schrier RW. Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells. J Clin Invest. 1992;90:1992-1999.
33. Smits P, Hersbach F, Jansen T, Thien T, Lutterman J. Impaired vasodilator response to atrial natriuretic factor in IDDM. Diabetes. 1993;42:1454-1461.
34. Owen NE. Effect of TPA on ion fluxes and DNA synthesis in vascular smooth muscle cells. J Cell Biol. 1985;101:454-459.
35. Ohmi K, Yamashita S, Nonomura Y. Effect of K525a, a protein kinase inhibitor, on the proliferation of vascular smooth muscle cells. Biochem Biophys Res Commun. 1990;173:976-981.
36. Dempsey EC, McMurtry IF, O'Brien RF. Protein kinase C activation allows pulmonary artery smooth muscle cells to proliferate to hypoxia. Am J Physiol. 1991;260:L136-L145.
37. Takagi Y, Hirata Y, Takata S, Yoshimi H, Fukuda Y, Fujita T, Hidaka H. Effects of protein kinase inhibitors on growth factor-stimulated DNA synthesis in cultured rat vascular smooth muscle cells Atherosclerosis. 1988;74:227-230.
38. Huang C-L, Ives HE. Growth inhibition by protein kinase C late in mitogenesis. Nature. 1987;329:849-850.
39. Kariya K, Fukumoto Y, Tsuda T, Kawahara Y, Fukuzaki H, Yamamoto T, Takai Y. Inhibition of DNA synthesis by phorbol esters through protein kinase C in cultured rabbit aortic smooth muscle cells. FEBS Lett. 1987;217:69-73.
40. Matsumoto H, Sasaki Y. Staurosporine, a protein kinase C inhibitor, interferes with proliferation of arterial smooth muscle cells. Biochem Biophys Res Commun. 1989;158:105-109.
41. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol. 1995;15:2207-2212.
42. Stiles CD, Capone GT, Scher CD, Antoniades HN, VanWyk JJ, Pledger WJ. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acadi Sci U S A. 1979;76:1279-1283.
43. Kleinert HD, Maack T, Atlas SA, Januszewic ZA, Sealey JE, Laragh JH. Atrial natriuretic factor inhibits angiotensin, norepinephrine and potassium induced vascular contractility. Hypertension. 1984;6(suppl I):I-143-I-147.
44. Abell TJ, Richard AM, Ikram H, Espiner EA, Yandle Y. Atrial factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun. 1989; 160:1392-1396.